MedCity News
DECEMBER 26, 2024
Corxel Pharmaceuticals has acquired an oral small molecule GLP-1 agonist with potential applications in obesity and diabetes. The Phase 2-ready pill could compete with oral metabolic meds in development by companies such as Roche, AstraZeneca, and Structure Therapeutics. The post The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender appeared first on MedCity News.
PharmaTech
DECEMBER 26, 2024
Challenges that can prevent sponsors realizing the full potential of managed access programs can be overcome by embracing a just-in-time manufacturing strategy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 26, 2024
A $4.75m grant will support the development of EIS-12656, which is being studied alone and in combination with PARP inhibitors.
PharmaTech
DECEMBER 26, 2024
The launch of Roche's cobas mass spectrometry solution will bring fully automated mass spec analysis to the clinical lab.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmExec
DECEMBER 26, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
PharmaTech
DECEMBER 26, 2024
Pointing to the continued circulation and evolution of COVID-19, WHO published a statement on the COVID-19 vaccine antigen composition to respond to variants of the virus.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmExec
DECEMBER 26, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
DECEMBER 26, 2024
AstraZeneca and Daiichi Sankyo have withdrawn marketing authorisation application in the EU voluntarily, intended for datopotamab deruxtecan.
PharmExec
DECEMBER 26, 2024
In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses the biggest misconceptions about fertility that he sees circulating on social media and work he does to correct and prevent them.
Pharmaceutical Technology
DECEMBER 26, 2024
Immune globulin (human) is under clinical development by Grifols and currently in Phase II for Tachycardia (Tachyarrhythmias).
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
DECEMBER 26, 2024
Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.
Pharmaceutical Technology
DECEMBER 26, 2024
Allergen for Grass Pollen Allergy is under clinical development by Roxall Medizin and currently in Phase II for Grass Pollen Allergy.
Pharmacy Times
DECEMBER 26, 2024
High levels of the Oscillibacter genus of bacteria were associated with reduced cholesterol.
Pharmaceutical Technology
DECEMBER 26, 2024
Darigabat is under clinical development by Cerevel Therapeutics and currently in Phase II for Seizures.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmacy Times
DECEMBER 26, 2024
Yi Lin, MD, PhD, highlights the importance of achieving MRD negativity in multiple myeloma, CAR T-cell therapy outcomes, and the critical role of pharmacists in patient care.
Pharmaceutical Technology
DECEMBER 26, 2024
Nelivaptan is under clinical development by HMNC and currently in Phase II for Major Depressive Disorder.
MedCity News
DECEMBER 26, 2024
President-elect Donald Trump recently appointed former Paypal executive David Sacks as the White Houses first-ever czar for AI and cryptocurrency. Ryan Tarzy CEO of Avandra Imaging, a federated network for de-identified imaging data thinks this appointment could help accelerate the pace of innovation in the healthcare industry. The post Why One Startup CEO Is Excited About the White Houses New AI Czar Role appeared first on MedCity News.
Pharmaceutical Technology
DECEMBER 26, 2024
Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol-Myers Squibb and currently in Phase I for Sarcomas.
Fierce Pharma
DECEMBER 26, 2024
As the life sciences industry prepares for a new administration, cutting edge technology and more, there are plenty of challenges in store for 2025and much to be optimistic about, too. Thats according to the Deloitte U.S. Center for Health Solutions, which found in a recent survey of 150 C-suite executives across the global life sciences sphere that 75% of respondents are optimistic about the year ahead.
Pharmaceutical Technology
DECEMBER 26, 2024
Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol-Myers Squibb and currently in Phase I for Osteosarcoma.
Pharmaceutical Technology
DECEMBER 26, 2024
Tricaprilin is under clinical development by Cerecin and currently in Phase II for Infantile Spasm (West Syndrome).
Pharmaceutical Technology
DECEMBER 26, 2024
KGYY-15 is under clinical development by Op-T-Mune and currently in Phase I for Type 1 Diabetes (Juvenile Diabetes).
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmaceutical Technology
DECEMBER 26, 2024
Lidocaine is under clinical development by MEDRx and currently in Pre-Registration for Postherpetic Neuralgia.
Pharmaceutical Technology
DECEMBER 26, 2024
StemVacs-V is under clinical development by Res Nova Bio and currently in Phase II for Metastatic Breast Cancer.
Expert insights. Personalized for you.
107 
Let's personalize your content